KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

West Pharmaceutical Services (WST) Current Assets (2016 - 2025)

Historic Current Assets for West Pharmaceutical Services (WST) over the last 17 years, with Q3 2025 value amounting to $1.8 billion.

  • West Pharmaceutical Services' Current Assets rose 1758.67% to $1.8 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $1.8 billion, marking a year-over-year increase of 1758.67%. This contributed to the annual value of $1.5 billion for FY2024, which is 2056.91% down from last year.
  • As of Q3 2025, West Pharmaceutical Services' Current Assets stood at $1.8 billion, which was up 1758.67% from $1.7 billion recorded in Q2 2025.
  • In the past 5 years, West Pharmaceutical Services' Current Assets registered a high of $2.0 billion during Q3 2023, and its lowest value of $1.3 billion during Q1 2021.
  • For the 5-year period, West Pharmaceutical Services' Current Assets averaged around $1.7 billion, with its median value being $1.7 billion (2024).
  • Per our database at Business Quant, West Pharmaceutical Services' Current Assets surged by 3575.45% in 2021 and then tumbled by 2138.11% in 2024.
  • Over the past 5 years, West Pharmaceutical Services' Current Assets (Quarter) stood at $1.7 billion in 2021, then rose by 10.19% to $1.9 billion in 2022, then grew by 0.88% to $1.9 billion in 2023, then dropped by 20.57% to $1.5 billion in 2024, then grew by 18.54% to $1.8 billion in 2025.
  • Its Current Assets was $1.8 billion in Q3 2025, compared to $1.7 billion in Q2 2025 and $1.5 billion in Q1 2025.